A critical challenge in the development of antibody: Selecting the appropriate fragment of the target protein as an antigen based on various epitopes or similar structure-Reference-Cited by-同舟云学术

A critical challenge in the development of antibody: Selecting the appropriate fragment of the target protein as an antigen based on various epitopes or similar structure

Published:2019-07 Issue: Volume:111 Page:128-135
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Razzaqi Mahboubeh^ORCID,Rasaee Mohammad Javad,Paknejad Maliheh

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference21 articles.

1. Epitope-based peptide vaccine design against mokola rabies virus glycoprotein g utilizing in silico;Aa;Immunome Res.,2017

2. Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant;Amorim;Vaccine,2012

3. Determination immunogenic property of truncated MrpH.FliC as a vaccine candidate against urinary tract infections caused by Proteus mirabilis;Bameri;Microb. Pathog.,2018

4. Recombinant protein truncation strategy for inducing bactericidal antibodies to the macrophage infectivity potentiator protein of Neisseria meningitidis and circumventing potential cross-reactivity with human FK506-binding proteins;Bielecka;Infect. Immun.,2015

5. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding;Bradford;Anal. Biochem.,1976

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Roadmap to Pyruvate Kinase M2 Modulation - A Computational Chronicle;Current Drug Targets;2023-04

2. An In-silico Approach and Experimental Analysis Combination: Two Strategies for Selecting the third Extracellular Domain (D-EC3) of Human CD133 Marker as a Target for Detection of Cancer Stem Cells;IRAN J PHARM RES;2021

3. A promising cancer diagnosis and treatment strategy: targeted cancer therapy and imaging based on antibody fragment;Artificial Cells, Nanomedicine, and Biotechnology;2019-08-30